Diaceutics PLC (DXRX) - Total Liabilities

Latest as of June 2025: GBX7.18 Million GBX ≈ $873.84 USD

Based on the latest financial reports, Diaceutics PLC (DXRX) has total liabilities worth GBX7.18 Million GBX (≈ $873.84 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore DXRX shareholders equity momentum to track the company's year-over-year net asset growth rate.

Diaceutics PLC - Total Liabilities Trend (2015–2024)

This chart illustrates how Diaceutics PLC's total liabilities have evolved over time, based on quarterly financial data. See DXRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Diaceutics PLC Competitors by Total Liabilities

The table below lists competitors of Diaceutics PLC ranked by their total liabilities.

Company	Country	Total Liabilities
TELES Informationstechnologien AG XETRA:TLIK	Germany	€4.29 Million
Airesis SA SW:AIRE	Switzerland	CHF208.50 Million
AGM Group Holdings Inc Class A NASDAQ:AGMH	USA	$28.66 Million
SRx Health Solutions Inc. NYSE MKT:SRXH	USA	$8.00 Million
Rainbow Polikarbonat Sanayi Ticaret AS IS:RNPOL	Turkey	TL1.38 Billion
Fitness Champs Holdings Limited Common Stock NASDAQ:FCHL	USA	$1.90 Million
Sienna Resources Inc V:SIE	Canada	CA$137.82K
Linkers Industries Limited Class A Ordinary Shares NASDAQ:LNKS	USA	$8.38 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Diaceutics PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Diaceutics PLC.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diaceutics PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diaceutics PLC (2015–2024)

The table below shows the annual total liabilities of Diaceutics PLC from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX8.76 Million ≈ $1.07K	+57.66%
2023-12-31	GBX5.56 Million ≈ $676.25	-3.20%
2022-12-31	GBX5.74 Million ≈ $698.64	+31.58%
2021-12-31	GBX4.36 Million ≈ $530.97	+33.01%
2020-12-31	GBX3.28 Million ≈ $399.20	+46.54%
2019-12-31	GBX2.24 Million ≈ $272.42	-56.78%
2018-12-31	GBX5.18 Million ≈ $630.37	+43.37%
2017-12-31	GBX3.61 Million ≈ $439.69	+48.82%
2016-12-31	GBX2.43 Million ≈ $295.45	+106.72%
2015-12-31	GBX1.17 Million ≈ $142.92	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$1.48 Million

GBX12.14 Billion GBX

Market Cap Rank

#30271 Global

#740 in UK

Share Price

GBX143.50

Change (1 day)

+5.13%

52-Week Range

GBX126.50 - GBX176.50

All Time High

GBX187.50